Clover End Period Cash Flow from 2010 to 2024

CLOV Stock  USD 3.23  0.04  1.25%   
Clover Health End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow will likely drop to about 152.8 M in 2024. During the period from 2010 to 2024, Clover Health End Period Cash Flow regression line of quarterly data had mean square error of 3529.8 T and geometric mean of  90,527,321. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-12-31
Previous Quarter
254.8 M
Current Value
288 M
Quarterly Volatility
125.5 M
 
Covid
Check Clover Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clover Health's main balance sheet or income statement drivers, such as Interest Expense of 6.7 K, Other Operating Expenses of 1.8 B or Minority Interest of 3.1 M, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.0 or PTB Ratio of 1.68. Clover financial statements analysis is a perfect complement when working with Clover Health Valuation or Volatility modules.
  
Check out the analysis of Clover Health Correlation against competitors.

Latest Clover Health's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Clover Health Investments over the last few years. It is Clover Health's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clover Health's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Clover End Period Cash Flow Regression Statistics

Arithmetic Mean105,982,962
Geometric Mean90,527,321
Coefficient Of Variation65.37
Mean Deviation52,211,246
Median75,403,000
Standard Deviation69,284,611
Sample Variance4800.4T
Range272M
R-Value0.56
Mean Square Error3529.8T
R-Squared0.32
Significance0.03
Slope8,725,407
Total Sum of Squares67205T

Clover End Period Cash Flow History

2024152.8 M
2023176.5 M
2022186.2 M
2021300 M
202028 M
201967.6 M

About Clover Health Financial Statements

Clover Health investors use historical fundamental indicators, such as Clover Health's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Clover Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow176.5 M152.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clover Stock Analysis

When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.